Outcomes following acute primary angle closure in an Asian population
Background: Data regarding development of primary angle closure glaucoma (PACG) following acute primary angle closure (APAC) is conflicting. This study looks at outcomes after an APAC episode with a secondary aim to identify any risk factors that could predict progression to PACG. Methods: This is...
Saved in:
Published in | Clinical & experimental ophthalmology Vol. 37; no. 5; pp. 467 - 472 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Melbourne, Australia
Blackwell Publishing Asia
01.07.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: Data regarding development of primary angle closure glaucoma (PACG) following acute primary angle closure (APAC) is conflicting. This study looks at outcomes after an APAC episode with a secondary aim to identify any risk factors that could predict progression to PACG.
Methods: This is a retrospective review of the charts of consecutive patients who were diagnosed with APAC from December 2003 to June 2006. All were treated in a standard manner with initial intensive medical therapy or laser iridoplasty followed by early laser peripheral iridotomy within 24 h of presentation.
Results: Forty‐two eyes of 41 patients were analysed. The mean follow‐up period was 27.3 ± 16.2 months. Nine eyes (21.4%) developed an increase in intraocular pressure (IOP) within a mean of 11.9 months (median 5 months) after resolution of APAC. Eight eyes went on to have trabeculectomy or glaucoma drainage device. At final follow up, the mean IOP of attack eye was 13.3 ± 2.92 mmHg. None of the eyes, including those that underwent surgery, required topical medication to control IOP. Thirty‐eight eyes (90.5%) have BCVA of 6/6 to 6/12. The duration of symptoms before presentation (P = 0.00) and duration taken to abort the acute attack (P = 0.01) were found to be significantly associated with development of PACG.
Conclusion: The results of this study suggest that outcomes following successful treatment of APAC may not be as poor as described previously. Early aggressive management of the acute episode may have a role to play in preventing development of PACG after APAC. |
---|---|
Bibliography: | ark:/67375/WNG-ZVC6VX9M-9 ArticleID:CEO2060 istex:08A19B2AB113A19B9C95AFD0C5D8E435CEEB0649 Financial disclosure: The authors have no financial interest in any of the products mentioned in the article. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1442-6404 1442-9071 |
DOI: | 10.1111/j.1442-9071.2009.02060.x |